ZAP70 in chronic lymphocytic leukaemia

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 9, 2008, Pages 1654-1658

  Amin, Shilu ^a   Parker, Anton ^b   Mann, Jelena ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Epigenetics; ZAP70

Indexed keywords

PROTEIN KINASE ZAP 70;

CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; DNA METHYLATION; HUMAN; NONHUMAN; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 44949180807     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.05.016     Document Type: Short Survey

References (24)

1. Boncristiano M., Majolini M.B., D'Elios M.M., Pacini S., Valensin S., Ulivieri, et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. European Journal of Immunology 30 (2000) 2632-2638
2. Brdicka T., Kadlecek T.A., Roose J.P., Pastuszak A.W., and Weiss A. Intramolecular regulatory switch in ZAP-70: Analogy with receptor tyrosine kinases. Molecular and Cellular Biology 25 (2005) 4924-4933
3. Castro J.E., Prada C.E., Loria O., Kamal A., Chen L., Burrows F.J., et al. ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: Inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood 106 (2005) 2506-2512
4. Chan A.C., Iwashima M., Turck C.W., and Weiss A. ZAP-70: A 70 kD protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71 (1992) 649-662
5. Chen L., Apgar J., Huynh L., Dicker F., Giago-McGahan T., Rassenti L., et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 105 (2005) 2036-2041
6. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic lymphocytic leukemia. The New England Journal of Medicine 352 (2005) 804-815
7. Corcoran M., Parker A., Orchard J., Davis Z., Wirtz M., Schmitz O.J., et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 90 (2005) 1078-1088
8. Crespo M., Villamor N., Gine E., Muntanola A., Colomer D., Marafioti, et al. ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. Clinical Cancer Research 12 (2006) 726-734
9. Elder M.E., Skoda-Smith S., Kadlecek T.A., Wang F., Wu J., and Weiss A. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. Journal of Immunology 166 (2001) 656-661
10. Gobessi S., Laurenti L., Longo P.G., Sica S., Leone G., and Efremov D.G. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood 109 (2007) 2032-2039
11. Gu Y., Chae H.D., Siefring J.E., Jasti A.C., Hildeman D.A., and Williams D.A. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nature Immunology 7 (2006) 1182-1190
12. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
13. Kuroyama H., Ikeda T., Kasai M., Yamasaki S., Tatsumi M., Utsuyama M., et al. Identification of a novel isoform of ZAP-70, truncated ZAP kinase. Biochemical and Biophysical Research Communications 315 (2004) 935-941
14. Mustelin T., and Tasken K. Positive and negative regulation of T-cell activation through kinases and phosphatases. The Biochemical Journal 371 (2003) 15-27
15. Nolz J.C., Tschumper R.C., Pittner B.T., Darce J.R., Kay N.E., and Jelinek D.F. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype. Leukemia 19 (2005) 1018-1024
16. Orchard J., Ibbotson R., Best G., Parker A., and Oscier D. ZAP-70 in B cell malignancies. Leukemia & Lymphoma 46 (2005) 1689-1698
17. Raval A., Byrd J.C., and Plass C. Epigenetics in chronic lymphocytic leukemia. Seminars in Oncology 33 (2006) 157-166
18. Richardson S.J., Matthews C., Catherwood M.A., Alexander H.D., Carey B.S., Farrugia J., et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 107 (2006) 3584-3592
19. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426 (2003) 454-460
20. Scielzo C., Camporeale A., Geuna M., Alessio M., Poggi A., Zocchi M.R., et al. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage. Leukemia 20 (2006) 689-695
21. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 16899-16903
22. Ticchioni M., Charvet C., Noraz N., Lamy L., Steinberg M., Bernard A., et al. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood 99 (2002) 3111-3118
23. Wange R.L. TCR signaling: Another Abl-bodied kinase joins the cascade. Current Biology 14 (2004) R562-R564
24. Wiestner A., Rosenwald A., Barry T.S., Wright G., Davis R.E., Henrickson S., et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101 (2003) 4944-4951